Marubeni Chemix

Marubeni Chemix is a specialized non clinical CRO(contract research organization). They offer viral safety evaluation and many more. They provide smooth execution of high-quality non-clinical testing with their partnered GLP-compliant facilities in Japan.

Features of Marubeni Chemix’s Non-clinical Contract Services

Japanese-language support for seamless study coordination

Marubeni Chemix serves as the primary point of contact and manages all communication with partnered laboratories, such as LabCorp and RIAS (Research Institute for Biological Sciences and Safety).

Studies are conducted both in Japan and global partnered facilities. They serve as a lieson between clients and those facilities. This provides their clients a relief through all stages of processes—contracts, study requests, and reporting all can be done in Japanese. This significantly reduces the burden of English documentation and time-zone-related miscommunication.

Broad technical capabilities across key study areas

The company supports a wide range of non-clinical studies and various stages od R&D, including toxicity, pharmacokinetics, safety pharmacology, and carcinogenicity.

Evaluations in the early drug discovery stage, such as lead optimization and candidate selection are also available.

Marubeni Chemix has established an integrated framework that enables consistent support from screening through IND submission. Flexible study design and high implementation accuracy are among their strengths.

Full coverage from small molecules to advanced modalities

Through our partnership with LabCorp, Marubeni Chemix can provides studies for small-molecules, next-generation modalities, such as biopharmaceuticals, cell and gene therapies, and vaccines. LabCorp can also provide optimized study designs for high-molecular-weight compounds and has extensive experience with GLP-compliant toxicology and bridging studies for global regulatory submissions.

This robust support system is especially suitable for companies who are developing innovative modalities.

Marubeni Chemix’s Partnered CRO

Research Institute for Biological Sciences and Safety (RIAS)

RIAS is a testing and research organization staffed by nationally certified veterinarians, pharmacists, clinical laboratory technologists, and specialists in agriculture, chemistry, and biology.

For nearly 40 years, the institute has conducted a wide scope of GLP-compliant studies, including toxicity and safety testing for veterinary drugs, feed additives, and chemical substances, as well as microbiological testing, pharmacological evaluations, and clinical studies.

RIAS is the only certified facility in Japan for rabies antibody testing and is highly trusted by pharmaceutical companies and regulatory authorities. The institute is also active in supporting regulatory submissions and conducting academic research.

Reference: https://www.riasbt.jp/pages/19/

Non-clinical Study Example (Marubeni Chemix / RIAS)

Viral clearance studies at GLP-compliant facilities

Marubeni Chemix coordinates viral clearance studies for biologically derived products as part of non-clinical viral safety evaluation. These studies validate the virus inactivation and removal processes to ensure product quality and safety.

All studies are conducted at GLP-compliant facilities in Japan, enabling the procuring of reliable, guideline-compliant data. Support is also available for preparing study reports for overseas regulatory submissions.

Reference:Labcorp Holdings Inc.

:https://www.marubenichemix.co.jp/service/copy_service_03.html

Company Information

Testing Site: Research Institute for Biological Sciences and Safety (RIAS)